The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Krishna Kishore Kuchipudi
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 4.9 pts more than Nifty Microcap 250 and 5.4 pts more than its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Krishna Kishore Kuchipudi, Promoter and Managing Director of Jeevan Scientific Technology Ltd, has acquired 12,00,000 (Twelve Lakh) convertible warrants through a preferential issue dated January 2, 2026. Before this acquisition, he held 21,35,113 shares representing 13.48% voting rights in the company. After the preferential allotment, the total equity share capital of the company expanded from 1,58,33,965 shares to 1,99,18,965 shares, and his overall economic interest (shares plus warrants) rose to 33,35,113 units, equivalent to 14.24% on a fully diluted basis. The disclosure was filed under Regulation 29(2) of the SEBI Takeover Regulations to formally report the change in his shareholding.
This signals promoter confidence in the company's future, as the Managing Director is personally subscribing to the preferential issue with his own funds. Existing shareholders should note that the promoter's effective control (on a diluted basis) increases to 14.24%, though on a non-diluted basis his percentage appears lower (10.72%) due to the expanded share base.